Oxidative Medicine and Cellular Longevity / 2019 / Article / Fig 4

Research Article

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway

Figure 4

Determination of signaling pathways after Nrf2 knockdown in mouse heart. (a, b) Myr treatment inhibited the phosphorylation and nuclei translocation of p65; (c, d) Myr treatment inhibited the phosphorylation of TAK1/p38/JNK1/2 after Nrf2 knockdown, , versus the scram group or the scram+Myr group, # versus the shRNA+AB group.
(a)
(b)
(c)
(d)